Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Aurinia Pharmaceuticals, Inc.

Home Clinical Trial Sponsors and OrganizationsAurinia Pharmaceuticals, Inc.

Aurinia Pharmaceuticals, Inc.

ACTIVE

Canadawww.auriniapharma.comPublic300 employeesEstablished: 2011-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

8 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2011

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

8

100.0%

Trial Status Distribution

Active, not recruiting

8

100.0%

Clinical Trials

Trials sponsored by this organization (8)

A clinical study to assess the long-term safety and efficacy of Orelvo (voclosporin) compared with placebo in subjects with active lupus nephritis (LN)

Active, not recruiting

Apr 2018324 participants

A clinical study to assess the long-term safety and efficacy of Orelvo (voclosporin) compared with placebo in subjects with active lupus nephritis (LN)

Active, not recruiting

Apr 2018324 participants

A clinical study to assess the long-term safety and efficacy of Orelvo (voclosporin) compared with placebo in subjects with active lupus nephritis (LN)

Active, not recruiting

Jan 2018324 participants

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephritis - AURORA (AURinia Orelvo Renal Assessments) 1: Aurinia Renal Response in Active Lupus with Voclosporin

Active, not recruiting

Sep 2017357 participants

A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)

Active, not recruiting

Aug 2017324 participants

A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)

Active, not recruiting

Apr 2017324 participants

A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)

Active, not recruiting

Mar 2017324 participants

A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephritis - AURORA (AURinia Orelvo Renal Assessments) 1: Aurinia Renal Response in Active Lupus with Voclosporin

Active, not recruiting

Mar 2017357 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations